Skip to main content
Premium Trial:

Request an Annual Quote

Emory and Georgia Tech Earn $10 Million NIH Roadmap Grants

NEW YORK, Oct. 7 (GenomeWeb News) - Emory University and the Georgia Institute of Technology on Wednesday received two National Institutes of Health grants of $10 million to establish a multidisciplinary research program in cancer nanotechnology.

 

Suming Nie, who holds a dual appointment as associate professor of biomedical engineering at Georgia Tech and Emory Unversity and is director of cancer nanotechnology at Emory's Winship Cancer Institute, will serve as principal investigator.

 

The two institutions earned a five-year $7.1 million grant from the National Cancer Institute to develop nanoscale tools for linking molecular signatures to cancer behavior and clinical outcome. Additionally, they earned a four-year, $2.7 million grant to develop nanoscale probes for molecular and cellular imaging of cancer.

 

The funding is part of the new NIH Roadmap Initiative.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.